Impact of β3-adrenergic receptor agonist on kidney cancer risk in patients with overactive bladder

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2025-05-09 DOI:10.1111/bju.16771

Jee Soo Park, Soo Beom Choi, Jongchan Kim, Won Sik Jang, Won Sik Ham

引用次数: 0

Abstract

To determine the effect of β₃-adrenergic receptor (AR) agonist on the risk of kidney cancer in patients with overactive bladder (OAB).

查看原文本刊更多论文

β3-肾上腺素能受体激动剂对膀胱过度活动患者肾癌风险的影响

目的探讨β3-肾上腺素能受体（AR）激动剂对膀胱过动症（OAB）患者发生肾癌风险的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.